These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1679571)

  • 21. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ambulatory treatment of rheumatoid arthritis with gold salts].
    Zborovskiĭ AB; Levshina AM
    Sov Med; 1990; (2):71-2. PubMed ID: 2356534
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The chrysotherapy of patients with Reiter's disease].
    Kovalev IuN; Il'in II
    Ter Arkh; 1991; 63(12):123-5. PubMed ID: 1687091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of aurotherapy on the content of corticotropin, cortisol, aldosterone and insulin in the blood serum of rheumatoid arthritis patients].
    Ornat SIa
    Vrach Delo; 1991 Jan; (1):61-5. PubMed ID: 1672783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The potentials of colchicine in the combined therapy of secondary amyloidosis in patients with rheumatoid arthritis].
    Kanevskaia MZ; Chichasova NV; Varshavskiĭ VA; Krel' AA
    Ter Arkh; 1991; 63(5):93-7. PubMed ID: 1887431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Wollenhaupt J; Zeidler H
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1219-23. PubMed ID: 9378046
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of aurotherapy on the level of unsaturated fatty acids during the treatment of rheumatoid arthritis patients].
    Virstiuk NH
    Lik Sprava; 1997; (5):166-70. PubMed ID: 9491733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [History of the discovery of gold salts action in rheumatoid polyarthritis].
    Forestier F; De Sèze S
    Rev Prat; 1992 Sep; 42(14):1804-6. PubMed ID: 1362286
    [No Abstract]   [Full Text] [Related]  

  • 32. [2 cases of fibrosing alveolitis in patients with rheumatoid arthritis treated with chrysanol].
    Repnitskaia ZD; Sunegin KB
    Klin Med (Mosk); 1990 Sep; 68(9):99-100. PubMed ID: 1981247
    [No Abstract]   [Full Text] [Related]  

  • 33. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of psoriatic arthritis with gold salts (chrysotherapy)].
    Burdeĭnyĭ AP; Sigidin IaA; Novoselova TM
    Ter Arkh; 1986; 58(7):38-43. PubMed ID: 3532401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of combined chrisanol and balneological treatment on the clinical indicators and permeability of the synovian membrane in patients with rheumatoid arthritis].
    Taletene IP; Gaigalene BA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):28-31. PubMed ID: 6730385
    [No Abstract]   [Full Text] [Related]  

  • 37. IgA deficiency and drug induced IgA deficiency in rheumatoid arthritis.
    Mbuyi JM; Dequeker J; Francx L
    J Rheumatol; 1983 Oct; 10(5):829-31. PubMed ID: 6644713
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.